Atlas Trials

Intensified Rituimab Prephase Before FCR in Untreated B-CLL

Clinical trial NCT01370772 · COMPLETED

Trial details

NCT number
NCT01370772
Sponsor
French Innovative Leukemia Organisation
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
B-cell Chronic Lymphocytic Leukemia CLL
Start date
2011-05-01
Primary completion
2014-09-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.